BLISS GVS PHARMA
Quarterly Results Analysis [Dec2023]
BLISS GVS PHARMA Quarterly Results
Consolidated | Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 UnAudited |
Dec2022 UnAudited |
Sep2022 Audited |
Jun2022 UnAudited |
Mar2022 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹201 Cr | ₹212 Cr | ₹160 Cr | ₹185 Cr | ₹206 Cr | ₹172 Cr | ₹189 Cr | ₹167 Cr |
Expenses | ₹157 Cr | ₹158 Cr | ₹135 Cr | ₹179 Cr | ₹158 Cr | ₹148 Cr | ₹150 Cr | ₹147 Cr |
Operating Income | ₹44 Cr | ₹54 Cr | ₹24 Cr | ₹6 Cr | ₹48 Cr | ₹25 Cr | ₹39 Cr | ₹20 Cr |
Other Income | ₹5 Cr | ₹13 Cr | ₹5 Cr | ₹3 Cr | ₹6 Cr | ₹2 Cr | ₹7 Cr | ₹12 Cr |
Interest | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹5 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr |
Depreciation | ₹7 Cr | ₹6 Cr | ₹6 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹4 Cr |
Profit Before Tax | ₹40 Cr | ₹59 Cr | ₹22 Cr | ₹-1 Cr | ₹47 Cr | ₹20 Cr | ₹39 Cr | ₹26 Cr |
Profit After Tax | ₹29 Cr | ₹43 Cr | ₹14 Cr | ₹3 Cr | ₹30 Cr | ₹16 Cr | ₹27 Cr | ₹23 Cr |
EPS | ₹2.64 | ₹4.05 | ₹1.41 | ₹0.32 | ₹2.68 | ₹1.33 | ₹2.48 | ₹1.89 |
Industry Peers & Returns | 1W | 1M | 1Y |
BLISS GVS PHARMA | 6.1% | 5.8% | 50.3% |
SUN PHARMACEUTICAL INDUSTRIES | -2.3% | -6.5% | 55.3% |
CIPLA | 4.1% | -4.8% | 55.6% |
DR REDDYS LABORATORIES | 4% | 0.8% | 29.4% |
ZYDUS LIFESCIENCES | -1.2% | -5.2% | 83.9% |
DIVIS LABORATORIES | 7.8% | 17.4% | 20.3% |
MANKIND PHARMA | 1.3% | 7% | NA |
TORRENT PHARMACEUTICALS | 3.9% | 5.1% | 66.1% |
LUPIN | 0.6% | 0.5% | 127.2% |
BLISS GVS PHARMA Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -5.27 % |
Y-o-Y | -2.43 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹201 Cr | -5.27 | |
Sep2023 | ₹212 Cr | 32.82 | |
Jun2023 | ₹160 Cr | -13.67 | |
Mar2023 | ₹185 Cr | -10.18 | |
Dec2022 | ₹206 Cr | 19.30 | |
Sep2022 | ₹172 Cr | -8.60 | |
Jun2022 | ₹189 Cr | 12.93 | |
Mar2022 | ₹167 Cr | - |
BLISS GVS PHARMA Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -19.63 % |
Y-o-Y | -8.38 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹44 Cr | -19.63 | |
Sep2023 | ₹54 Cr | 124.54 | |
Jun2023 | ₹24 Cr | 287.97 | |
Mar2023 | ₹6 Cr | -86.91 | |
Dec2022 | ₹48 Cr | 94.28 | |
Sep2022 | ₹25 Cr | -36.82 | |
Jun2022 | ₹39 Cr | 92.67 | |
Mar2022 | ₹20 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -15.16 % |
Y-o-Y | -6.08 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 21.77% | -15.16 | |
Sep2023 | 25.66% | 69.04 | |
Jun2023 | 15.18% | 349.11 | |
Mar2023 | 3.38% | -85.42 | |
Dec2022 | 23.18% | 62.90 | |
Sep2022 | 14.23% | -30.89 | |
Jun2022 | 20.59% | 70.59 | |
Mar2022 | 12.07% | - |
BLISS GVS PHARMA Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -32.46 % |
Y-o-Y | -2.41 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹29 Cr | -32.46 | |
Sep2023 | ₹43 Cr | 199.44 | |
Jun2023 | ₹14 Cr | 314.62 | |
Mar2023 | ₹3 Cr | -88.36 | |
Dec2022 | ₹30 Cr | 86.16 | |
Sep2022 | ₹16 Cr | -41.76 | |
Jun2022 | ₹27 Cr | 17.10 | |
Mar2022 | ₹23 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -28.74 % |
Y-o-Y | 0.00 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 14.48 % | -28.74 | |
Sep2023 | 20.32 % | 125.53 | |
Jun2023 | 9.01 % | 379.26 | |
Mar2023 | 1.88 % | -87.02 | |
Dec2022 | 14.48 % | 56.03 | |
Sep2022 | 9.28 % | -36.26 | |
Jun2022 | 14.56 % | 3.63 | |
Mar2022 | 14.05 % | - |
BLISS GVS PHARMA Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -34.81 % |
Y-o-Y | -1.49 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹2.64 | -34.81 | |
Sep2023 | ₹4.05 | 187.23 | |
Jun2023 | ₹1.41 | 340.63 | |
Mar2023 | ₹0.32 | -88.06 | |
Dec2022 | ₹2.68 | 101.50 | |
Sep2022 | ₹1.33 | -46.37 | |
Jun2022 | ₹2.48 | 31.22 | |
Mar2022 | ₹1.89 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD